EUVIMEDEUVIMED entdecken
Crossref

Unraveling the Potential of Empagliflozin to Counteract 1,2‐Dimethylhydrazine‐Induced Colorectal Cancer in Rats: Involvement of Redox Imbalance, Inflammatory Cascades, and Unprogrammed Cell Proliferation

Hager Abd Al-Hamid iD, Mohamed O Mahmoud iD, Mona R El-Ansary iD, Noha F Hassan iD, Safaa B Gomaa

Journal of Biochemical and Molecular Toxicology · 2026-05 · 40 (5)

DOI: 10.1002/jbt.70886 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 14.05.2026. Verfasst von Hager Abd Al-Hamid und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry Department, Faculty of Pharmacy, Modern University for Technology and Information, Cairo, Egypt. Hauptthemen laut MEDLINE: 1,2-Dimethylhydrazine, Glucosides, Colorectal Neoplasms, Cell Proliferation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 88 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Globally, colorectal cancer ranks second in terms of mortality and is the third most frequent cancer. This study was designed to evaluate empagliflozin ability to suppress the progression of 1,2‐dimethylhydrazine (DMH)‐induced colorectal cancer. An 8‐week regimen of 40 mg/kg/twice a week of DMH to generate colorectal cancer. Three groups of eight male Wistar rats were created as follows: normal control, DMH group and DMH + empagliflozin (30 mg/kg; p.o.). The colonic levels of the antioxidant enzymes; superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) were restored, empagliflozin adjusted the redox imbalance provoked by DMH. Immunohistochemical study proved the impact of empagliflozin in downregulating nuclear factor kappa B (NF‐κB) that was elevated by DMH. Empagliflozin counteracted the DMH‐triggered inflammation by reducing vascular endothelial growth factor (VEGF), interlukin‐6 (IL‐6) and cyclooxygenase‐2 (COX‐2) levels. Empagliflozin hindered tumor cell proliferation which has supported by the decline in proliferating cell nuclear antigen (PCNA) mRNA expression. Empagliflozin halted the DMH‐activated oncogenic phosphatidylinositol 3 kinase (PI3K)/protein kinase B (Akt)/the mammalian target of rapamycin (mTOR) signaling pathway, demonstrated by western blot analysis. Histopathological assessment verified that empagliflozin suppressed the formation of dysplastic aberrant crypt foci (ACF). Empagliflozin has been suggested to suppress the progression of colorectal carcinogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

1,2-DimethylhydrazineGlucosidesColorectal NeoplasmsCell ProliferationAnimalsMaleRats, WistarRatsOxidation-ReductionInflammationSignal TransductionOxidative StressCyclooxygenase 2Benzhydryl Compounds

Stichwörter der Autor:innen

AktDMHPI3Kcolorectal cancerempagliflozin

Substanzen

1,2-DimethylhydrazineempagliflozinGlucosidesCyclooxygenase 2Benzhydryl Compounds

Autor:innen und Institutionen

  • Biochemistry Department, Faculty of Pharmacy, Modern University for Technology and Information, Cairo, Egypt.
  • Biochemistry Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt.
  • Pharmacology and Toxicology Department, Faculty of Pharmacy, Modern University for Technology and Information, Cairo, Egypt.

ORCID-Profile: Hager Abd Al-Hamid, Mohamed O Mahmoud, Mona R El-Ansary, Noha F Hassan

Zitieren

APA

Al-Hamid, H. A., Mahmoud, M. O., El-Ansary, M. R., Hassan, N. F., & Gomaa, S. B. (2026). Unraveling the Potential of Empagliflozin to Counteract 1,2‐Dimethylhydrazine‐Induced Colorectal Cancer in Rats: Involvement of Redox Imbalance, Inflammatory Cascades, and Unprogrammed Cell Proliferation. Journal of Biochemical and Molecular Toxicology, 40(5). https://doi.org/10.1002/jbt.70886

Vancouver

Al-Hamid HA, Mahmoud MO, El-Ansary MR, Hassan NF, Gomaa SB. Unraveling the Potential of Empagliflozin to Counteract 1,2‐Dimethylhydrazine‐Induced Colorectal Cancer in Rats: Involvement of Redox Imbalance, Inflammatory Cascades, and Unprogrammed Cell Proliferation. Journal of Biochemical and Molecular Toxicology. 2026;40(5). doi:10.1002/jbt.70886

BibTeX
@article{AlHamid2026,
  author = {Al-Hamid, Hager Abd and Mahmoud, Mohamed O and El-Ansary, Mona R and Hassan, Noha F and Gomaa, Safaa B},
  title = {Unraveling the Potential of Empagliflozin to Counteract 1,2‐Dimethylhydrazine‐Induced Colorectal Cancer in Rats: Involvement of Redox Imbalance, Inflammatory Cascades, and Unprogrammed Cell Proliferation},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2026},
  volume = {40},
  number = {5},
  doi = {10.1002/jbt.70886}
}
Kostenlos starten →